Improvements in corticosteroid 21-acetoxy-17α-hydroxy-16α-methyl-pregna-1,4,9(11)-triene-3,20-dione synthesis and its use as common intermediate in the synthesis of some impurities related to dexamethasone and mometasone

Add time:07/26/2019    Source:sciencedirect.com

There are quite substantial number of impurities related to dexamethasone or mometasone which cannot be made from respective Active Pharmaceutical Ingredients but from common intermediate 21-acetoxy-17α-hydroxy-16α-methyl-pregna-1,4,9(11)-triene-3,20-dione (12). As such, a robust and economical synthesis of this key intermediate is important for delivering a resilient and economically viable supply chain for these impurities. Therefore, it is critical to have a robust and economically viable process to synthesize the intermediate 12 in good yield and quality. We report here an improved synthesis of 12 and eight impurities related to dexamethasone and mometasone from this common intermediate.

We also recommend Trading Suppliers and Manufacturers of (17α)-17-Hydroxy-3-oxo-19-norpregna-5(10),9(11)-diene-21-nitrile (cas 106111-42-6). Pls Click Website Link as below: cas 106111-42-6 suppliers

Prev:Screening for strains with 11α-hydroxylase activity for 17α-hydroxy progesterone biotransformation
Next:Adsorption of 17α-ethynyl estradiol and β-estradiol on graphene oxide surface: An experimental and computational study)